NCT04322695 is a NA clinical trial of Rehabilitation Education Care Program in Head and Neck Cancer, sponsored by Chang Gung University of Science and Technology.

Who is sponsoring NCT04322695?

NCT04322695 is sponsored by Chang Gung University of Science and Technology.

What drugs are being tested in NCT04322695?

Interventions in NCT04322695: Rehabilitation Education Care Program.

What condition does NCT04322695 study?

NCT04322695 studies Head and Neck Cancer.

Is NCT04322695 still recruiting?

NCT04322695 is currently status unknown. Last updated 22 July 2022.

Last reviewed 2022-07-22 · How we verify

NCT04322695

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Rehabilitation Education Care Program on Return to Work Among Head and Neck Cancer Survivors

Status unknown NA Last updated 22 July 2022

What this trial tests

NA trial testing Rehabilitation Education Care Program in Head and Neck Cancer in 120 participants. Status unknown.

Timeline

31 July 2021

Primary endpoint
30 July 2023

31 July 2023

Quick facts

Lead sponsor	Chang Gung University of Science and Technology
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	120
Start date	31 July 2021
Primary completion	30 July 2023
Estimated completion	31 July 2023
Sites	1 location across Taiwan

Drugs / interventions tested

Rehabilitation Education Care Program

Conditions studied

Head and Neck Cancer — all drugs for Head and Neck Cancer →

Sponsor

Chang Gung University of Science and Technology

Who can join

Adults 18 to 65, any sex, with Head and Neck Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study will to identify factors (performance ability, physical function, psychosocial function, fear of cancer progression, social support, demographic characteristics, and disease-related characteristics) that impact the Return to work and work status in survivors of HNC within one year after completion treatment. Head and neck cancer survivors who have attended a rehabilitation education care program (RECP) intervention will have better performance ability, physical function, psychosocial function, fear of cancer progress, social support, and lower return to work to patients who not attended with the intervention.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Non-medical interventions to enhance return to work for people with cancer.
de Boer AG, Tamminga SJ, Boschman JS, Hoving JL. · · 2024 · cited 21× · PMID 38441440 · DOI 10.1002/14651858.cd007569.pub4
Effects of a return to work program on the health and barriers to returning to work in head and neck cancer patients: A randomized controlled trial.
Chang YL, Huang BS, Lin CY, Chung CF, et al · · 2023 · cited 5× · PMID 38059206 · DOI 10.1016/j.apjon.2023.100320

Verify or expand the search:

Other recruiting trials for Head and Neck Cancer

Currently open trials in the same condition.

NCT07318220 — Prehabilitation Protocol for Head and Neck Cancer Patients · NA · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07467083 — Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Unde · Phase 3 · recruiting
NCT07209189 — Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca · Phase 2 · recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema · NA · recruiting

Other Chang Gung University of Science and Technology trials

Trials by the same sponsor.

NCT07310849 — Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity · NA · enrolling by invitation
NCT07191600 — Talking Pen Audio-Interactive Program for Oral Frailty Delay in Community-Dwelling Elderly · NA · not yet recruiting
NCT07110389 — Effectiveness of a Tele-cardiac Rehabilitation (Tele-CR) Program · NA · enrolling by invitation
NCT07053592 — Community Beauty and Health Program for Older Adults: An Experiential Learning Trial · NA · not yet recruiting
NCT07124845 — Using Multimedia Cases Combined With Focused Conversation in Enhancing Nursing Students' Mental Health Literacy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04322695 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chang Gung University of Science and Technology
Last refreshed: 22 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04322695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing